These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 16472955

  • 1. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging.
    Saksena MA, Saokar A, Harisinghani MG.
    Eur J Radiol; 2006 Jun; 58(3):367-74. PubMed ID: 16472955
    [Abstract] [Full Text] [Related]

  • 2. Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer.
    Tabatabaei S, Harisinghani M, McDougal WS.
    J Urol; 2005 Sep; 174(3):923-7; discussion 927. PubMed ID: 16093989
    [Abstract] [Full Text] [Related]

  • 3. Lymphotrophic nanoparticle enhanced MR imaging (LNMRI) for lymph node imaging.
    Saokar A, Braschi M, Harisinghani M.
    Abdom Imaging; 2006 Sep; 31(6):660-7. PubMed ID: 16680506
    [Abstract] [Full Text] [Related]

  • 4. Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy.
    Ross RW, Zietman AL, Xie W, Coen JJ, Dahl DM, Shipley WU, Kaufman DS, Islam T, Guimaraes AR, Weissleder R, Harisinghani M.
    Clin Imaging; 2009 Sep; 33(4):301-5. PubMed ID: 19559353
    [Abstract] [Full Text] [Related]

  • 5. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
    Montie JE.
    J Urol; 2005 Sep; 174(3):870-1. PubMed ID: 16093977
    [No Abstract] [Full Text] [Related]

  • 6. Overview of nanoparticle use in cancer imaging.
    Islam T, Harisinghani MG.
    Cancer Biomark; 2009 Sep; 5(2):61-7. PubMed ID: 19414922
    [Abstract] [Full Text] [Related]

  • 7. Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model.
    Pandharipande PV, Mora JT, Uppot RN, Goehler A, Braschi M, Halpern EF, Gazelle GS, Harisinghani MG.
    AJR Am J Roentgenol; 2009 Sep; 193(3):W230-7. PubMed ID: 19696264
    [Abstract] [Full Text] [Related]

  • 8. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?
    Harisinghani MG, Saksena MA, Hahn PF, King B, Kim J, Torabi MT, Weissleder R.
    AJR Am J Roentgenol; 2006 Jan; 186(1):144-8. PubMed ID: 16357394
    [Abstract] [Full Text] [Related]

  • 9. Re: Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer.
    Kroon BK, Horenblas S.
    J Urol; 2006 Mar; 175(3 Pt 1):1174. PubMed ID: 16469648
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study.
    Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P, Saini S, Maravilla KR, Feldman DE, Schmiedl UP, Brunberg JA, Francis IR, Harms SE, Som PM, Tempany CM, Group.
    Radiology; 2003 Sep; 228(3):777-88. PubMed ID: 12954896
    [Abstract] [Full Text] [Related]

  • 11. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
    Deserno WM, Harisinghani MG, Taupitz M, Jager GJ, Witjes JA, Mulders PF, Hulsbergen van de Kaa CA, Kaufmann D, Barentsz JO.
    Radiology; 2004 Nov; 233(2):449-56. PubMed ID: 15375228
    [Abstract] [Full Text] [Related]

  • 12. Pearls and pitfalls of MR lymphography in gynecologic malignancy.
    Narayanan P, Iyngkaran T, Sohaib SA, Reznek RH, Rockall AG.
    Radiographics; 2009 Nov; 29(4):1057-69; discussion 1069-71. PubMed ID: 19605656
    [Abstract] [Full Text] [Related]

  • 13. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10.
    Tatsumi Y, Tanigawa N, Nishimura H, Nomura E, Mabuchi H, Matsuki M, Narabayashi I.
    Gastric Cancer; 2006 Nov; 9(2):120-8. PubMed ID: 16767368
    [Abstract] [Full Text] [Related]

  • 14. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
    Choi SH, Moon WK, Hong JH, Son KR, Cho N, Kwon BJ, Lee JJ, Chung JK, Min HS, Park SH.
    Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
    [Abstract] [Full Text] [Related]

  • 15. Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging.
    Heesakkers RA, Jager GJ, Hövels AM, de Hoop B, van den Bosch HC, Raat F, Witjes JA, Mulders PF, van der Kaa CH, Barentsz JO.
    Radiology; 2009 May; 251(2):408-14. PubMed ID: 19401573
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide.
    Nishimura H, Tanigawa N, Hiramatsu M, Tatsumi Y, Matsuki M, Narabayashi I.
    J Am Coll Surg; 2006 Apr; 202(4):604-11. PubMed ID: 16571430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.